Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard O Boehm

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Expert Opinion on Investigational Drugs|August 29, 2003
The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetesBernhard O Boehm
The New England Journal of Medicine|May 3, 2005
Insulin analoguesBernhard O Boehm
Developments in Ophthalmology|January 25, 2007
Use of long-acting somatostatin analogue treatment in diabetic retinopathyBernhard O Boehm
Diabetes/Metabolism Research and Reviews|May 27, 2010
Processing and presentation of (pro)-insulin in the MHC class II pathway: the generation of antigen-based immunomodulators in the context of type 1 diabetes mellitusTimo Burster, Bernhard O Boehm
Pharmacogenomics|September 12, 2002
The impact of pharmacogenomics on gastrointestinal cancer therapyThomas Seufferlein, Bernhard O Boehm
Thrombosis Research|September 3, 2021
Thrombosis post COVID-19 vaccinations: Potential link to ACE pathwaysRinkoo Dalan, Bernhard O Boehm
Clinical Nutrition ESPEN|January 22, 2022
Micronutrient supplementation before COVID-19 vaccination can protect against adverse effectsRinkoo Dalan, Bernhard O Boehm
Clinical Nutrition ESPEN|May 27, 2022
Reply - Letter to the editor: "Micronutrient supplementation, COVID-19 vaccination and adverse effect"Rinkoo Dalan, Bernhard O Boehm
Diabetes/Metabolism Research and Reviews|September 2, 2020
The implications of COVID-19 infection on the endothelium: A metabolic vascular perspectiveRinkoo Dalan, Bernhard O Boehm
Best Practice & Research. Clinical Gastroenterology|June 25, 2002
Use of somatostatin receptor ligands in obesity and diabetic complicationsBernhard O Boehm, Robert H Lustig
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Expert Opinion on Investigational Drugs|August 29, 2003
The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetesBernhard O Boehm
The New England Journal of Medicine|May 3, 2005
Insulin analoguesBernhard O Boehm
Developments in Ophthalmology|January 25, 2007
Use of long-acting somatostatin analogue treatment in diabetic retinopathyBernhard O Boehm
Diabetes/Metabolism Research and Reviews|May 27, 2010
Processing and presentation of (pro)-insulin in the MHC class II pathway: the generation of antigen-based immunomodulators in the context of type 1 diabetes mellitusTimo Burster, Bernhard O Boehm
Pharmacogenomics|September 12, 2002
The impact of pharmacogenomics on gastrointestinal cancer therapyThomas Seufferlein, Bernhard O Boehm
Thrombosis Research|September 3, 2021
Thrombosis post COVID-19 vaccinations: Potential link to ACE pathwaysRinkoo Dalan, Bernhard O Boehm
Clinical Nutrition ESPEN|January 22, 2022
Micronutrient supplementation before COVID-19 vaccination can protect against adverse effectsRinkoo Dalan, Bernhard O Boehm
Clinical Nutrition ESPEN|May 27, 2022
Reply - Letter to the editor: "Micronutrient supplementation, COVID-19 vaccination and adverse effect"Rinkoo Dalan, Bernhard O Boehm
Diabetes/Metabolism Research and Reviews|September 2, 2020
The implications of COVID-19 infection on the endothelium: A metabolic vascular perspectiveRinkoo Dalan, Bernhard O Boehm
Best Practice & Research. Clinical Gastroenterology|June 25, 2002
Use of somatostatin receptor ligands in obesity and diabetic complicationsBernhard O Boehm, Robert H Lustig
Pageof 26